2016
DOI: 10.13075/mp.5893.00466
|View full text |Cite
|
Sign up to set email alerts
|

Fullerenols in therapy and diagnosis of cancer

Abstract: StreszczenieDo głównych przyczyn zgonów w Polsce zalicza się nowotwory złośliwe. Jednym z celów współczesnych badań biomedycznych jest zmaksymalizowanie efektów działania stosowanych strategii leczniczych. Podejmowane działania doskonalące środki terapeutyczne są ukierunkowane na ograniczenie działań niepożądanych terapii przeciwnowotworowych. Innym kierunkiem badań jest poszukiwanie substancji ochronnych, które zmniejszą toksyczność leków wobec komórek prawidłowych. Nanotechnologia umożliwia projektowanie wys… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
7
0

Year Published

2017
2017
2022
2022

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 13 publications
(7 citation statements)
references
References 39 publications
0
7
0
Order By: Relevance
“…Additionally, Flr could have an anti-inflammatory effect on the organism after treatment with DOX. On the other hand, current knowledge indicates that fullerenols show low or no toxicity [52] and may contribute to the inhibition of tumor growth and the protection of normal cells through their antioxidant properties, as well as to the regulation of expression of genes involved in apoptosis and angiogenesis, and stimulation of the immune response in humans [52]. Accordingly, pretreatment with Frl did not affect the DOX anticancer activity in the current study.…”
Section: Discussionmentioning
confidence: 47%
“…Additionally, Flr could have an anti-inflammatory effect on the organism after treatment with DOX. On the other hand, current knowledge indicates that fullerenols show low or no toxicity [52] and may contribute to the inhibition of tumor growth and the protection of normal cells through their antioxidant properties, as well as to the regulation of expression of genes involved in apoptosis and angiogenesis, and stimulation of the immune response in humans [52]. Accordingly, pretreatment with Frl did not affect the DOX anticancer activity in the current study.…”
Section: Discussionmentioning
confidence: 47%
“…This discovery further leads to quick progresses in biomaterials field of study (Danilenko, 2006; Goodarzi et al, 2017). Fullerenes and NDs have recently gained a great attention among biomedical scientists, with stress mainly on the field of cancer diagnosis and therapy (Liu et al, 2010; Lichota and Krokosz, 2016). NDs are the products of the famous diamond in nano scale, which are typically recovered from explosion powder.…”
Section: The Rise Of Carbon-family Nanomaterials: New Roles In Medicinementioning
confidence: 99%
“…However, depending on the research protocol applied, fullerenol may also act as prooxidant [53]. This dualistic nature of fullerenols may contribute to the future development of some new biomedical and environmental applications of these agents [54][55][56].…”
Section: Discussionmentioning
confidence: 99%